GEMALTO
Gemalto, the world leader in digital security, today announced the availability of three new cloud-based Hardware Security Module (HSM) services, HSM On Demand for CyberArk , HSM On Demand for Hyperledger and HSM On Demand for Oracle TDE . Each service is available through the SafeNet Data Protection on Demand platform, a marketplace of cloud-based HSM, encryption and key management services that easily integrates with most widely used cloud services and IT products to protect data wherever it is created, accessed or stored.
The rapid adoption of cloud and digital services has made it difficult for organizations to secure data and identities that are created, stored and managed outside the perimeter. While organizations recognize that data encryption is the optimal solution to secure sensitive information, they can be challenged by the cost and complexity of deploying encryption, including Hardware Security Modules to secure their cryptographic operations. Gemalto’s SafeNet Data Protection On Demand solves these challenges by providing cloud-based HSM services that and can be deployed in minutes without the need for highly skilled staff. Gemalto, a leader in the HSM market, is proven to help customers secure their encryption keys and data across cloud, hybrid, and on-premises environments.
“A worsening threat landscape, combined with aggressive cloud adoption and evolving privacy regulations, have presented complex new challenges related to encryption, privileged access and financial transactions,” said Todd Moore, Senior Vice President of Encryption Products at Gemalto. “Our newest Cloud HSM On Demand services help organizations stay in front of new threats and regulations, by easily deploying an HSM solution for the strongest possible key management and security practices, all while providing fast, easy set-up, with remarkable savings over traditional approaches involving specialized hardware and skills.”
“Many organizations would like to deploy data security more broadly, but are often wary due to concerns about complexity, cost and staffing requirements, particularly with respect to encryption and key management,” said Garrett Bekker, Principal Analyst at 451 Research. “The release of SafeNet Data Protection On Demand was a positive step towards addressing those concerns, and extending its cloud HSM capability to newer use cases like blockchain, database security and privileged credentials is a logical and timely move.”
HSM On Demand for CyberArk
HSM
On Demand for CyberArk
works seamlessly with CyberArk’s Privileged
Access Security Solution, providing private key protection and strong
entropy for key generation for system keys.. By securing the master key
and ensuring that it is hosted in a secure vault, HSM On Demand for
CyberArk mitigates the risk of the master key being exposed or
compromised.
HSM On Demand for Hyperledger
HSM
On Demand for Hyperledger
provides trust for blockchain transactions
by securing the cryptographic keys that sign them. It protects digital
wallets, while ensuring keys are readily available in the cloud once
access is granted. The service provides high assurance security in data
centers and the cloud, enabling multi-tenancy of blockchain identities
per partition as proof of transaction and for auditing requirements. It
also delivers performance improvements resulting from off-loading
cryptographic operations from application servers to the HSM on Demand
service.
HSM On Demand for Oracle TDE
HSM
for Oracle TDE
(Transparent Data Encryption) solves the challenge
presented by locally stored encryption keys by protecting them with a
master key, stored in a separate service key vault. This ensures that
only authorized services are allowed to request the local key to be
decrypted. If an attacker steals the database, it is encrypted and
inaccessible, since the attacker does not have access to the keys that
are securely stored on the HSM.
Additional Resources
- HSM On Demand for CyberArk Overview
- HSM on Demand for CyberArk Integration Guide
- HSM On Demand for Hyperledger Integration Guide
- HSM On Demand for Oracle TDE Integration Guide
- Blog: Choosing the Right Cloud HSM
About Gemalto
Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security , with 2018 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.
From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.
Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.
Our 15,000 employees operate out of 110 offices, 47 personalization and data centers, and 35 research and software development centers located in 47 countries.
For more information visit www.gemalto.com , or follow @gemalto on Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190305005648/en/
Contact:
Gemalto media contacts: Tauri Cox North America +1 512 257 3916 tauri.cox@gemalto.com
Sophie Dombres Europe Middle East & Africa +33 4 42 36 57 38 sophie.dombres@gemalto.com
Jaslin Huang Asia Pacific +65 6317 3005 jaslin.huang@gemalto.com
Alexis Camarillo Latin America +52 5521223627 alexis.camarillo@gemalto.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
